Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1996;74(6):619–628.

Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus.

V Dietz 1, J B Milstien 1, F van Loon 1, S Cochi 1, J Bennett 1
PMCID: PMC2486793  PMID: 9060223

Abstract

Neonatal tetanus (NT) is a major cause of mortality in developing countries, with over 400,000 deaths estimated to occur annually. WHO has adopted the goal of eliminating NT worldwide, and a major strategy for its prevention is the administration of at least two properly spaced doses of tetanus toxoid (TT) to women of childbearing age in high-risk areas to protect passively their newborns at birth. In certain countries the locally produced TT vaccine has been shown to be subpotent, while other countries have reported NT among infants born to vaccinated women. An extensive review of production and quality control procedures was carried out between 1993 and 1995 in 8 of 22 TT-producing countries that also report NT cases, with a more superficial assessment being carried out in the remaining 14 countries. Only 4 of the 22 countries have a functioning national control authority to monitor TT production and vaccine quality. A total of 80 TT lots from 21 manufacturers in 14 of the 22 NT-reporting countries were tested for potency. Of these, 15 lots from eight manufacturers in seven countries had potency values below WHO requirements. TT potency can also be compromised by improper vaccine handling. To eliminate neonatal tetanus worldwide requires assurance that all doses of TT meet WHO production and quality requirements and that the field effectiveness of TT is monitored through systematic NT case investigations and assessment of coverage.

Full text

PDF
619

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J., Azhar N., Rahim F., Kamil S., Traverso H., Killgore G., Boring J. Further observations on ghee as a risk factor for neonatal tetanus. Int J Epidemiol. 1995 Jun;24(3):643–647. doi: 10.1093/ije/24.3.643. [DOI] [PubMed] [Google Scholar]
  2. Bhat G. J., Joshi M. K., Kandoth P. W. Neonatal tetanus--a clinical study of 100 cases. Indian Pediatr. 1979 Feb;16(2):159–166. [PubMed] [Google Scholar]
  3. Bjerregaard P., Steinglass R., Mutie D. M., Kimani G., Mjomba M., Orinda V. Neonatal tetanus mortality in coastal Kenya: a community survey. Int J Epidemiol. 1993 Feb;22(1):163–169. doi: 10.1093/ije/22.1.163. [DOI] [PubMed] [Google Scholar]
  4. Black R. E., Huber D. H., Curlin G. T. Reduction of neonatal tetanus by mass immunization of non-pregnant women: duration of protection provided by one or two doses of aluminium-adsorbed tetanus toxoid. Bull World Health Organ. 1980;58(6):927–930. [PMC free article] [PubMed] [Google Scholar]
  5. Bwire R., Kawuma H. J. Hospital-based study on neonatal tetanus, Buluba Hospital, 1985-1989. J Trop Med Hyg. 1992 Feb;95(1):62–66. [PubMed] [Google Scholar]
  6. Chen S. T., Edsall G., Peel M. M., Sinnathuray T. A. Timing of antenatal tetanus immunization for effective protection of the neonate. Bull World Health Organ. 1983;61(1):159–165. [PMC free article] [PubMed] [Google Scholar]
  7. Cárdenas Ayala V. M., Núez Urquiza R. M., Brogan D. R., Ibarra Rosales J. M., Gatica Valdés N., Smith T. E., Galván Arriaga S., Flores Collins M. E., Escobar Mesa A. Neonatal tetanus mortality in Veracruz, Mexico, 1989. Bull Pan Am Health Organ. 1995 Jun;29(2):116–128. [PubMed] [Google Scholar]
  8. Deivanayagam N., Nedunchelian K., Kamala K. G. Neonatal tetanus: observations on antenatal immunization, natal and immediate post-natal factors. Indian J Pediatr. 1991 Jan-Feb;58(1):119–122. doi: 10.1007/BF02810424. [DOI] [PubMed] [Google Scholar]
  9. Dhillon H., Menon P. S. Active immunization of women in pregnancy with two injections of adsorbed tetanus toxoid for prevention of tetanus neonatorum in Punjab, India. Indian J Med Res. 1975 Apr;63(4):583–589. [PubMed] [Google Scholar]
  10. Ghosh J. B. Prevention of tetanus neonatorum. Indian Pediatr. 1990 Feb;27(2):210–210. [PubMed] [Google Scholar]
  11. Hlady W. G., Bennett J. V., Samadi A. R., Begum J., Hafez A., Tarafdar A. I., Boring J. R. Neonatal tetanus in rural Bangladesh: risk factors and toxoid efficacy. Am J Public Health. 1992 Oct;82(10):1365–1369. doi: 10.2105/ajph.82.10.1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kim-Farley R., Sokhey J. A simple screening method for field evaluation of vaccine efficacy. J Commun Dis. 1988 Mar;20(1):32–37. [PubMed] [Google Scholar]
  13. Kumar H., Aneja S., Prasad V. K., Arora S. K., Mullick D. N. Tetanus neonatorum: clinico-epidemiological profile. Indian Pediatr. 1988 Nov;25(11):1054–1057. [PubMed] [Google Scholar]
  14. MacLennan R., Schofield F. D., Pittman M., Hardegree M. C., Barile M. F. Immunization against neonatal tetanus in New Guinea. Antitoxin response of pregnant women to adjuvant and plain toxoids. Bull World Health Organ. 1965;32(5):683–697. [PMC free article] [PubMed] [Google Scholar]
  15. Milstien J. B., Gellin B. G., Kane M., di Fabio J. L., Homma A. Global DTP manufacturing capacity and capability. Status report: January 1995. Vaccine. 1996 Mar;14(4):313–320. doi: 10.1016/0264-410x(95)00181-y. [DOI] [PubMed] [Google Scholar]
  16. Orenstein W. A., Bernier R. H., Dondero T. J., Hinman A. R., Marks J. S., Bart K. J., Sirotkin B. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63(6):1055–1068. [PMC free article] [PubMed] [Google Scholar]
  17. Owa J. A., Makinde O. O. Neonatal tetanus in babies of immunized mothers. J Trop Pediatr. 1990 Jun;36(3):143–144. doi: 10.1093/tropej/36.3.143. [DOI] [PubMed] [Google Scholar]
  18. Owa J. A., Makinde O. O. Neonatal tetanus in babies of women immunized with tetanus toxoid during pregnancy. Trop Doct. 1990 Oct;20(4):156–157. doi: 10.1177/004947559002000404. [DOI] [PubMed] [Google Scholar]
  19. Rahman M., Chen L. C., Chakraborty J., Yunus M., Chowdhury A. I., Sarder A. M., Bhatia S., Curlin G. T. Use of tetanus toxoid for the prevention of neonatal tetanus. 1. Reduction of neonatal mortality by immunization of non-pregnant and pregnant women in rural Bangladesh. Bull World Health Organ. 1982;60(2):261–267. [PMC free article] [PubMed] [Google Scholar]
  20. SCHOFIELD F. D., TUCKER V. M., WESTBROOK G. R. Neonatal tetanus in New Guinea. Effect of active immunization in pregnancy. Br Med J. 1961 Sep 23;2(5255):785–789. doi: 10.1136/bmj.2.5255.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Vernacchio L., Madico G., Verastegui M., Diaz F., Collins T. S., Gilman R. H. Neonatal tetanus in Peru: risk assessment with modified enzyme-linked immunosorbent assay and toxoid skin test. Am J Public Health. 1993 Dec;83(12):1754–1756. doi: 10.2105/ajph.83.12.1754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. de Moraes-Pinto M. I., Oruamabo R. S., Igbagiri F. P., Chan M. C., Prado S. M., Vancetto M. D., Johnson P. M., Hart C. A. Neonatal tetanus despite immunization and protective antitoxin antibody. J Infect Dis. 1995 Apr;171(4):1076–1077. doi: 10.1093/infdis/171.4.1076. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES